Patients [podg]    
Advanced [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Treated [ftcn]    
Retrospective Study [resa]    
Routine [qlco]    
practice [menp]    
Multi [qnco]    
institutions [idcn]    
Orally [spco]    
Administered [ftcn]    
Inhibitor [qlco]    
properties [qlco]    
LARGE [qnco]    
CLINICAL TRIALS [resa]    
Survival [acty]    
TIME [tmco]    
Progression [patf]    
Patients [podg]    
Advanced [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Present [qnco]    
Study [mnob]    
Patients [podg]    
Treated [ftcn]    
Multi [qnco]    
institutions [idcn]    
Korea [geoa]    
forms [qlco]    
CLINICAL TRIALS [resa]    
Methods [inpr]    
August [qlco]    
March [qlco]    
Patients [podg]    
Advanced [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Seven [qnco]    
Referral [hlca]    
Province [geoa]    
Korea [geoa]    
Evaluate [hlca]    
treatment [ftcn]    
Response [orga]    
Survival [acty]    
TOLERABILITY [resa]    
Following [tmco]    
Administration [ocac]    
treatment [ftcn]    
Response [orga]    
Assessed [acty]    
Response [orga]    
evaluation criteria [inpr]    
solid tumour [neop]    
Guidelines [inpr]    
Patients [podg]    
treatment [ftcn]    
HEPATOCELLULAR CARCINOMA [neop]    
Child-Pugh [inpr]    
CIRRHOSIS [dsyn]    
Median [spco]    
Duration [tmco]    
treatment [ftcn]    
DAYS [tmco]    
Range [qnco]    
DAYS [tmco]    
Median [spco]    
Survival [acty]    
Median [spco]    
TIME [tmco]    
Progression [patf]    
DAYS [tmco]    
>90 [qnco]    
DAYS [tmco]    
Complete Response [fndg]    
Partial Response [fndg]    
Stable Disease [fndg]    
Patients [podg]    
Median [spco]    
Survival [acty]    
Median [spco]    
TIME [tmco]    
Progression [patf]    
short [qlco]    
Patients [podg]    
Child-Pugh [inpr]    
CIRRHOSIS [dsyn]    
Compared [acty]    
Child-Pugh [inpr]    
CIRRHOSIS [dsyn]    
DAYS [tmco]    
DAYS [tmco]    
Child-Pugh [inpr]    
CIRRHOSIS [dsyn]    
Serum alpha-fetoprotein [lbpr]    
Independent [idcn]    
Risk Factors [qnco]    
Survival [acty]    
Thirty Nine [qnco]    
Patients [podg]    
experience [menp]    
Grade 4 Adverse Event [fndg]    
Hand Skin [bpoc]    
FOOT [bpoc]    
Reaction [ftcn]    
DIARRHOEA [sosy]    
Required [ftcn]    
Dose Adjustment [hlca]    
Conclusions [idcn]    
Treated [ftcn]    
Patients [podg]    
Advanced [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Reported [inpr]    
forms [qlco]    
Clinical Trial [resa]    
Conduct [inbe]    
Asia [geoa]    
Region [geoa]    
Hepatic dysfunction [patf]    
Important [qlco]    
Risk Factor [qnco]    
short [qlco]    
Survival [acty]    
